intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer rationale and report of early data腹腔内吉西他滨化疗治疗切除胰腺癌患者早期数据的原理和报告.pdfVIP

  • 2
  • 0
  • 约5.43万字
  • 约 8页
  • 2017-08-29 发布于上海
  • 举报

intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer rationale and report of early data腹腔内吉西他滨化疗治疗切除胰腺癌患者早期数据的原理和报告.pdf

intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer rationale and report of early data腹腔内吉西他滨化疗治疗切除胰腺癌患者早期数据的原理和报告

Hindawi Publishing Corporation International Journal of Surgical Oncology Volume 2011, Article ID 161862, 7 pages doi:10.1155/2011/161862 Review Article Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data Paul H. Sugarbaker, O. Anthony Stuart, and Lana Bijelic Washington Cancer Institute, 106 Irving Street, NW, Suite 3900, Washington, DC 20010, USA Correspondence should be addressed to Paul H. Sugarbaker, paul.sugarbaker@ Received 16 June 2011; Revised 8 Septe

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档